322 related articles for article (PubMed ID: 24612997)
1. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.
Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528
[TBL] [Abstract][Full Text] [Related]
3. Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18.
Rademacher J; Kill A; Mattat K; Dragun D; Siegert E; Günther J; Riemekasten G
J Rheumatol; 2016 Mar; 43(3):587-91. PubMed ID: 26773103
[TBL] [Abstract][Full Text] [Related]
4. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
5. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies.
Civieri G; Iop L; Tona F
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055116
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells.
Murthy S; Wannick M; Eleftheriadis G; Müller A; Luo J; Busch H; Dalmann A; Riemekasten G; Sadik CD
Rheumatology (Oxford); 2021 Jun; 60(6):3012-3022. PubMed ID: 33230552
[TBL] [Abstract][Full Text] [Related]
8. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
Front Immunol; 2021; 12():786039. PubMed ID: 34956217
[TBL] [Abstract][Full Text] [Related]
9. Agonistic antibodies in systemic sclerosis.
Moroncini G; Svegliati Baroni S; Gabrielli A
Immunol Lett; 2018 Mar; 195():83-87. PubMed ID: 29032187
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.
Avouac J; Riemekasten G; Meune C; Ruiz B; Kahan A; Allanore Y
J Rheumatol; 2015 Oct; 42(10):1801-7. PubMed ID: 26233500
[TBL] [Abstract][Full Text] [Related]
11. Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.
Cabral-Marques O; Riemekasten G
Autoimmun Rev; 2016 Jul; 15(7):690-4. PubMed ID: 26970493
[TBL] [Abstract][Full Text] [Related]
12. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
[TBL] [Abstract][Full Text] [Related]
13. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients.
O'Leary JG; Philippe A; Freeman R; Heidecke H; Jennings LW; Catar R; Klintmalm GB; Dragun D
Transplant Proc; 2021 Apr; 53(3):1019-1024. PubMed ID: 33579550
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
El Band JEK; Llorente S; Martinez-Garcia P; Alfaro R; Jimenez-Coll V; Boix F; Galián JA; Martinez-Banaclocha H; Botella C; Moya-Quiles MR; Minguela A; Legaz I; Muro M
Curr Protein Pept Sci; 2021; 22(10):745-757. PubMed ID: 34967284
[TBL] [Abstract][Full Text] [Related]
15. Functional autoantibodies in systemic sclerosis pathogenesis.
Kill A; Riemekasten G
Curr Rheumatol Rep; 2015 May; 17(5):34. PubMed ID: 25876754
[TBL] [Abstract][Full Text] [Related]
16. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course.
Miedema J; Schreurs M; van der Sar-van der Brugge S; Paats M; Baart S; Bakker M; Hoek R; Dik WA; Endeman H; Van Der Velden V; van Gammeren A; Ermens A; Aerts JG; Thüsen JV
Front Immunol; 2021; 12():684142. PubMed ID: 34054876
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune activation and hypersensitization of the AT1 and ETA receptors contributes to vascular injury in scleroderma renal crisis.
Hegner B; Kretzschmar T; Zhu N; Kleinau G; Zhao H; Kamhieh-Milz J; Hilger J; Schindler R; Scheerer P; Riemekasten G; Philippe A; Catar R
Rheumatology (Oxford); 2023 Jun; 62(6):2284-2293. PubMed ID: 36227102
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies Targeting AT
Catar R; Herse-Naether M; Zhu N; Wagner P; Wischnewski O; Kusch A; Kamhieh-Milz J; Eisenreich A; Rauch U; Hegner B; Heidecke H; Kill A; Riemekasten G; Kleinau G; Scheerer P; Dragun D; Philippe A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008670
[TBL] [Abstract][Full Text] [Related]
19. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
20. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
